• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性普拉克索治疗可提高正常及腹侧被盖区损伤大鼠对蔗糖的耐受性。

Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.

作者信息

Dardou David, Chassain Carine, Durif Franck

机构信息

EA7280 NPSY-Sydo, Université d'Auvergne Clermont-Ferrand, France.

IRM-Hopital Gabriel Montpied Clermont-Ferrand, France.

出版信息

Front Neurosci. 2015 Jan 6;8:437. doi: 10.3389/fnins.2014.00437. eCollection 2014.

DOI:10.3389/fnins.2014.00437
PMID:25610366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4285017/
Abstract

The loss of dopamine neurons observed in Parkinson's disease (PD) elicits severe motor control deficits which are reduced by the use of dopamine agonists. However, recent works have indicated that D3-preferential agonists such as pramipexole can induce impulse control disorders (ICDs) such as food craving or compulsive eating. In the present study, we performed an intermittent daily feeding experiment to assess the effect of chronic treatment by pramipexole and VTA bilateral lesion on tolerance for sucrose solution. The impact of such chronic treatment on spontaneous locomotion and spatial memory was also examined. Changes in sucrose tolerance could indicate the potential development of a change in food compulsion or addiction related to the action of pramipexole. Neither the bilateral lesion of the VTA nor chronic treatment with pramipexole altered the spontaneous locomotion or spatial memory in rats. Rats without pramipexole treatment quickly developed a stable intake of sucrose solution in the 12 h access phase. On the contrary, when under daily pramipexole treatment, rats developed a stronger and ongoing escalation of their sucrose solution intakes. In addition, we noted that the change in sucrose consumption was sustained by an increase of the expression of the Dopamine D3 receptor in the core and the shell regions of the nucleus accumbens. The present results may suggest that long-term stimulation of the Dopamine D3 receptor in animals induces a strong increase in sucrose consumption, indicating an effect of this receptor on certain pathological aspects of food eating.

摘要

在帕金森病(PD)中观察到的多巴胺能神经元缺失会引发严重的运动控制缺陷,而使用多巴胺激动剂可减轻这些缺陷。然而,最近的研究表明,像普拉克索这样的D3选择性激动剂会诱发冲动控制障碍(ICD),如食物渴望或强迫性进食。在本研究中,我们进行了一项间歇性每日喂食实验,以评估普拉克索慢性治疗和腹侧被盖区(VTA)双侧损伤对蔗糖溶液耐受性的影响。还研究了这种慢性治疗对自发运动和空间记忆的影响。蔗糖耐受性的变化可能表明与普拉克索作用相关的食物强迫或成瘾性变化的潜在发展。VTA双侧损伤和普拉克索慢性治疗均未改变大鼠的自发运动或空间记忆。未接受普拉克索治疗的大鼠在12小时进食阶段迅速形成了稳定的蔗糖溶液摄入量。相反,在每日接受普拉克索治疗时,大鼠的蔗糖溶液摄入量出现了更强且持续的增加。此外,我们注意到伏隔核核心区和壳区多巴胺D3受体表达的增加维持了蔗糖消耗的变化。目前的结果可能表明,长期刺激动物体内的多巴胺D3受体会导致蔗糖消耗大幅增加,表明该受体对进食的某些病理方面有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/9c0f813c80d7/fnins-08-00437-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/29b0476d1646/fnins-08-00437-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/894666e50ab4/fnins-08-00437-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/55c861252857/fnins-08-00437-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/26bf2dc35852/fnins-08-00437-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/98e7fed3363f/fnins-08-00437-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/9c0f813c80d7/fnins-08-00437-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/29b0476d1646/fnins-08-00437-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/894666e50ab4/fnins-08-00437-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/55c861252857/fnins-08-00437-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/26bf2dc35852/fnins-08-00437-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/98e7fed3363f/fnins-08-00437-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e3/4285017/9c0f813c80d7/fnins-08-00437-g0006.jpg

相似文献

1
Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.慢性普拉克索治疗可提高正常及腹侧被盖区损伤大鼠对蔗糖的耐受性。
Front Neurosci. 2015 Jan 6;8:437. doi: 10.3389/fnins.2014.00437. eCollection 2014.
2
Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats.腹侧被盖区前部多巴胺能神经元不参与溴隐亭、普拉克索和可卡因对未用药大鼠的动机性影响。
Behav Brain Res. 2014 Apr 1;262:1-7. doi: 10.1016/j.bbr.2013.12.021. Epub 2013 Dec 19.
3
Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.多巴胺受体激动剂普拉克索可逆转应激诱导的快感缺失。
Psychopharmacology (Berl). 1994 Aug;115(4):454-62. doi: 10.1007/BF02245568.
4
Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area.双侧腹侧被盖区后区损毁大鼠中多巴胺受体激动剂的差异行为强化效应。
Behav Brain Res. 2013 Sep 1;252:24-31. doi: 10.1016/j.bbr.2013.05.042. Epub 2013 May 31.
5
Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.帕金森病治疗可能通过多巴胺D3受体导致冲动控制障碍。
Synapse. 2015 Apr;69(4):183-9. doi: 10.1002/syn.21805. Epub 2015 Feb 3.
6
Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.6-羟基多巴胺诱导的帕金森病临床前期模型中脑源性神经营养因子(BDNF)和酪氨酸激酶受体B(trkB)mRNA表达的改变:慢性普拉克索对大鼠的影响
PLoS One. 2015 Mar 4;10(3):e0117698. doi: 10.1371/journal.pone.0117698. eCollection 2015.
7
Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area.长期使用普拉克索治疗会在黑质和腹侧被盖区有6-羟基多巴胺损伤的大鼠中诱发强迫行为。
Behav Brain Res. 2017 Aug 14;332:327-336. doi: 10.1016/j.bbr.2017.06.016. Epub 2017 Jun 17.
8
Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.普拉克索而非丙咪嗪或氟西汀可逆转帕金森病临床前期大鼠模型中的“抑郁样”行为。
Behav Brain Res. 2014 Sep 1;271:343-53. doi: 10.1016/j.bbr.2014.06.029. Epub 2014 Jun 20.
9
General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.一般来说,κ、δ 和 μ 阿片受体拮抗剂介导 GABA-B 激动剂巴氯芬在腹侧被盖区和伏隔核壳中引起的摄食:相互和区域相互作用。
Brain Res. 2012 Mar 14;1443:34-51. doi: 10.1016/j.brainres.2012.01.015. Epub 2012 Jan 17.
10
Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.低剂量普拉克索在帕金森病的MPTP小鼠模型中具有神经保护作用,并通过D3受体下调多巴胺转运体。
BMC Biol. 2004 Oct 11;2:22. doi: 10.1186/1741-7007-2-22.

引用本文的文献

1
Pramipexole Hyperactivates the External Globus Pallidus and Impairs Decision-Making in a Mouse Model of Parkinson's Disease.普拉克索使外部苍白球过度活跃,并损害帕金森病小鼠模型的决策能力。
Int J Mol Sci. 2024 Aug 14;25(16):8849. doi: 10.3390/ijms25168849.
2
Neuropsychiatric Disorders in Parkinson's Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?帕金森病中的神经精神障碍:我们对多巴胺能和非多巴胺能系统的作用了解多少?
Front Neurosci. 2020 Jan 29;14:25. doi: 10.3389/fnins.2020.00025. eCollection 2020.
3
Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists.

本文引用的文献

1
Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats.腹侧被盖区前部多巴胺能神经元不参与溴隐亭、普拉克索和可卡因对未用药大鼠的动机性影响。
Behav Brain Res. 2014 Apr 1;262:1-7. doi: 10.1016/j.bbr.2013.12.021. Epub 2013 Dec 19.
2
Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area.双侧腹侧被盖区后区损毁大鼠中多巴胺受体激动剂的差异行为强化效应。
Behav Brain Res. 2013 Sep 1;252:24-31. doi: 10.1016/j.bbr.2013.05.042. Epub 2013 May 31.
3
新型系列偏向信号传导多巴胺D3受体激动剂的功能表征
ACS Chem Neurosci. 2017 Mar 15;8(3):486-500. doi: 10.1021/acschemneuro.6b00221. Epub 2016 Nov 23.
4
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?啮齿动物模型能告诉我们关于帕金森病中的冷漠及相关神经精神症状的哪些信息?
Transl Psychiatry. 2016 Mar 8;6(3):e753. doi: 10.1038/tp.2016.17.
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.
帕金森病 6-羟多巴胺模型的行为特征及非运动缺陷的药物干预
Mol Neurodegener. 2013 Apr 26;8:14. doi: 10.1186/1750-1326-8-14.
4
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.吡贝地尔通过刺激 D2/D3 受体对帕金森病淡漠有效。
Brain. 2013 May;136(Pt 5):1568-77. doi: 10.1093/brain/awt067. Epub 2013 Mar 29.
5
The selective D₃ receptor antagonist SB-277011A attenuates morphine-triggered reactivation of expression of cocaine-induced conditioned place preference.选择性 D₃ 受体拮抗剂 SB-277011A 可减弱吗啡引发的可卡因诱导的条件性位置偏爱表达的再激活。
Synapse. 2013 Aug;67(8):469-75. doi: 10.1002/syn.21653. Epub 2013 Mar 25.
6
Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.多巴胺能黑质纹状体神经元的丧失是帕金森病中动机和情感缺陷的原因。
Mol Psychiatry. 2014 Mar;19(3):358-67. doi: 10.1038/mp.2013.3. Epub 2013 Feb 12.
7
Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and L-dopa, in bilateral 6-OHDA-lesioned rat.D2 和 D3 多巴胺受体激动剂以及可卡因的动机特性,而不是 D1 多巴胺受体激动剂和 L-多巴,在双侧 6-OHDA 损伤的大鼠中。
Neuropharmacology. 2013 Jul;70:74-82. doi: 10.1016/j.neuropharm.2012.12.011. Epub 2013 Jan 21.
8
Dopamine and food addiction: lexicon badly needed.多巴胺与食物成瘾:亟需词汇表。
Biol Psychiatry. 2013 May 1;73(9):e15-24. doi: 10.1016/j.biopsych.2012.09.027. Epub 2012 Nov 22.
9
The mysterious motivational functions of mesolimbic dopamine.中脑边缘多巴胺的神秘激励功能。
Neuron. 2012 Nov 8;76(3):470-85. doi: 10.1016/j.neuron.2012.10.021.
10
Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens? A ¹H nuclear MRS study.MPTP 中毒是否会导致小鼠伏隔核代谢物变化?一项¹H 核 MRS 研究。
NMR Biomed. 2013 Mar;26(3):336-47. doi: 10.1002/nbm.2853. Epub 2012 Oct 12.